Cedarburg, WI, United States of America

Eric Andrew Newenhouse



 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Eric Andrew Newenhouse: Innovator in Dendrimer-Resveratrol Complexes

Introduction

Eric Andrew Newenhouse is a notable inventor based in Cedarburg, WI (US). He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work involving dendrimer-resveratrol complexes. With a total of 4 patents to his name, Newenhouse is recognized for his advancements in treating various diseases.

Latest Patents

Newenhouse's latest patents focus on compositions comprising a dendrimer-resveratrol complex and methods for making and using these compositions. These patents describe methods for treating a wide range of conditions, including cancer, cardiovascular disease, diabetes, Alzheimer's disease, and many others. The compositions can be applied topically to skin or mucous membranes, providing therapeutic benefits to subjects in need.

Career Highlights

Eric Andrew Newenhouse is affiliated with Concordia University, where he continues to engage in research and development. His work has garnered attention for its potential impact on various health conditions, showcasing his commitment to innovation in the pharmaceutical field.

Collaborations

Newenhouse has collaborated with notable colleagues, including Abhay Singh Chauhan and Armin Henry Gerhardt. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Eric Andrew Newenhouse stands out as an influential inventor in the realm of pharmaceutical innovations. His work with dendrimer-resveratrol complexes holds promise for addressing numerous health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…